Globalink Investment Inc. logo

Globalink Investment Inc. (GLLI)

Delisted
25 Nov 2025
OTC PINK OTC PINK
$
1. 27
-0.02
-1.5504%
$
4.47M Market Cap
- P/E Ratio
- Div Yield
191,823 Volume
0 Eps
$ 1.29
Previous Close
Day Range
1.17 1.29
Year Range
0.81 15
Want to track GLLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

GLLI Chart

Globalink Investment Inc. (GLLI) FAQ

What does "Delisted" mean?

Globalink Investment Inc. has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

No stock splits were recorded prior to delisting.

What was the last known trading price?

The stock last traded at $1.27 on Nov 25, 2025 before being delisted.

Globalink Investment Inc. Profile

Trading Companies & Distributors Industry
Industrials Sector
Say Leong Lim CEO
OTC PINK Exchange
37892F109 CUSIP
US Country
- Employees
- Last Dividend
- Last Split
23 Dec 2021 IPO Date

Overview

Globalink Investment Inc. is a company with its focus set on the future, having been incorporated in the year 2021 and establishing its base in Newark, Delaware. Presently, the company does not engage in substantial operations. Instead, its core objective revolves around facilitating significant corporate maneuvers such as mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. The ambition driving Globalink Investment Inc. is to identify and assimilate businesses, particularly those operating within the medical technology and green energy sectors. This acquisition strategy is geographically targeted towards North America, Europe, and Southeast Asia, with an explicit exclusion of China, Hong Kong, and Macau, indicating a strategic focus on regions with burgeoning markets for these cutting-edge industries.

Products and Services

As Globalink Investment Inc. currently does not conduct significant operations on its own, its "products and services" essentially comprise the strategic corporate activities it intends to undertake. These include:

  • Mergers: The intention behind pursuing mergers is to combine with one or more businesses, creating a stronger, more competitive entity that can harness synergies and grow in the dedicated sectors of medical technology and green energy.
  • Share Exchanges: In share exchanges, Globalink facilitates processes where shares are exchanged between entities as part of acquisition deals, often aiming to leverage the strengths of different companies for enhanced market positioning.
  • Asset Acquisitions: This involves the direct purchase of valuable assets from target companies, specifically those that possess innovative technologies or advantageous market positions in the medical technology and green energy sectors.
  • Share Purchases: Similar to asset acquisitions, share purchase agreements are designed to acquire controlling interests in companies that align with Globalink's mission and strategic goals in its focused sectors.
  • Reorganizations: Engaging in reorganizations allows Globalink to streamline, restructure, or otherwise enhance the operations and efficiency of the entities it merges with or acquires, aiming to unlock value and optimize performance in pursuit of growth in its target industries.
  • Business Combinations: This broad category encompasses a variety of strategies aimed at consolidating businesses, technologies, and assets under the Globalink umbrella, focusing on creating a cohesive, powerful conglomerate that can drive innovations and growth within the medical technology and green energy sectors.

Contact Information

Address: 1180 Avenue of the Americas
Phone: 212 382 4605